Antipsychotics

Antipsychotics

Catalog Number Product Name CAS No. Inquiry
PI1187020809 Lumateperone Tosylate 1187020-80-9 Inquiry
PI122883936 Ziprasitone Hydrochloride 122883-93-6 Inquiry
PI30909514 Flupentixol Decanoate 30909-51-4 Inquiry
PI5002471 Fluphenazine Decanoate 5002-47-1 Inquiry

What Are Antipsychotics?

Antipsychotics, also known as neuroleptics, are a class of medications primarily used to manage psychotic disorders such as schizophrenia, schizoaffective disorder, and in some cases, bipolar disorder and severe depression. These drugs are designed to modify the effects of neurotransmitters in the brain, particularly dopamine and serotonin, which play key roles in mood regulation, perception, and cognition. Originally introduced in the 1950s, antipsychotics have significantly evolved over time, offering improved efficacy and fewer side effects. Today, they are essential tools in both acute and long-term psychiatric care. While these medications do not cure psychiatric disorders, they are vital in stabilizing patients and enabling them to function in daily life.

How Do Antipsychotics Work?

Antipsychotic drugs work by modulating the activity of neurotransmitters in the brain (primarily dopamine), which is often found in excess in people with psychosis. By blocking dopamine receptors, particularly D2 receptors, antipsychotics help to reduce symptoms such as delusions, hallucinations, and disorganized thinking. Some newer antipsychotics also affect serotonin receptors, which can help balance mood and reduce negative symptoms such as emotional withdrawal and lack of motivation. This dual-action mechanism is especially prominent in second-generation antipsychotics.

Types of Antipsychotics

Antipsychotics are broadly classified into two categories: first-generation (typical) and second-generation (atypical) antipsychotics.

First-Generation Antipsychotics (FGAs)

These were developed in the 1950s and include drugs such as haloperidol, chlorpromazine, and fluphenazine. FGAs are effective in treating positive symptoms of schizophrenia, such as hallucinations and delusions. However, they are associated with a higher risk of extrapyramidal side effects (EPS), including tremors, rigidity, and tardive dyskinesia, due to strong dopamine receptor antagonism.

Second-Generation Antipsychotics (SGAs)

SGAs, introduced in the 1990s, include drugs like risperidone, olanzapine, quetiapine, aripiprazole, and clozapine. These medications not only target dopamine but also influence serotonin receptors, resulting in a broader spectrum of activity. SGAs are generally preferred due to their lower risk of motor side effects and better efficacy against negative symptoms (e.g., social withdrawal, lack of motivation). However, they may carry metabolic risks, such as weight gain, diabetes, and lipid abnormalities.

Indications for Antipsychotic Use

Antipsychotics are prescribed for a variety of psychiatric and neurological conditions. Their main indications include:

  • Schizophrenia: Antipsychotics are the cornerstone of schizophrenia treatment, helping to control both positive symptoms (hallucinations, delusions) and negative symptoms (social withdrawal, lack of emotion).
  • Bipolar Disorder: Certain antipsychotics, such as quetiapine and aripiprazole, are approved for treating manic or mixed episodes and for maintenance therapy in bipolar disorder.
  • Major Depressive Disorder (MDD): Some atypical antipsychotics (e.g., aripiprazole, quetiapine XR) are used as adjunct therapy to antidepressants in treatment-resistant depression.
  • Delirium and Dementia-Related Psychosis: Low doses of antipsychotics may be used short-term to manage agitation or hallucinations, especially in elderly patients. However, caution is advised due to increased risk of adverse events.
  • Agitation and Psychosis in Dementia: Antipsychotics may be used off-label to manage severe agitation and psychosis in dementia patients when non-pharmacological interventions are ineffective. However, they carry a black box warning due to increased risks of mortality in elderly patients with dementia-related psychosis. Their use should be limited to cases where symptoms are severe, dangerous, or cause significant distress.
  • Delusional Disorder: Antipsychotics are employed in treating delusional disorders, helping to reduce the intensity and impact of delusional beliefs. Both typical and atypical antipsychotics can be effective, depending on the patient's response and side effect profile.
  • Autism Spectrum Disorder (ASD): Risperidone and aripiprazole are approved for treating irritability associated with ASD in children and adolescents, addressing symptoms like aggression, self-injury, and severe tantrums.
  • Tourette Syndrome and Other Tic Disorders: Medications like risperidone and haloperidol are occasionally prescribed to reduce tics and improve quality of life.
  • Borderline Personality Disorder (BPD): While not FDA-approved for BPD, antipsychotics are sometimes used off-label to manage transient psychotic episodes, mood instability, and impulsivity associated with the disorder.
  • Severe Anxiety Disorders: In rare cases, antipsychotics may be used to treat severe anxiety unresponsive to conventional treatments.
  • Childhood Schizophrenia: Early-onset schizophrenia in children and adolescents may be treated with antipsychotics, with clozapine showing benefits in treatment-resistant cases.

Partner with Us

Our company is dedicated to supplying high-quality APIs for pharmaceutical research and development. In the field of psychopharmacology, we offer a broad range of antipsychotic APIs, including both first-generation and second-generation compounds. Our portfolio includes but is not limited to haloperidol, risperidone, quetiapine, aripiprazole, olanzapine, ziprasidone, and clozapine. All our products are manufactured under stringent quality control systems and comply with international standards for research use. We support pharmaceutical manufacturers, academic researchers, and clinical developers in advancing mental health therapies through reliable and timely delivery of essential APIs.

Online Inquiry

Please kindly note that our services are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Verification code
For product and service inquiries icon1

For product and service inquiries, please use our online system or send an email to .

For product and service inquiries icon2